What Strategy Should Investors Adopt in Concord Biotech's Stock after Listing?

Concord Biotech's stock List on the NSE and BSE at a 21% premium.

Today, Concord Biotech's stock debuted on the NSE and BSE at a 21% premium. The stock opened at Rs. 900 on both exchanges, which is Rs. 159 higher than its offer price range of Rs. 705-741. Today market sentiment was very weak but despite this, the stock made its allottees rich.

Shares of Concord Biotech's were offered to the investors in the price band of rs. 705 - 741 per equity share and the issue received a very strong response from the investors. 

The rally has not even stopped even after the listing, it shows that investors are very optimistic about this stock. 

Concord Biotech's share touched an intraday high of 925.90 Rs. today. 

According to stock market experts, the fundamentals of Concord Biotech are very strong. 

Those who have not got these shares allotted can still find opportunities to buy in it or let it fall a bit and then think of entering this stock.